China SXT Pharmaceuticals (SXTC) Inventory (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Inventory of $2.2 million for Q1 2026, up 623.83% year-over-year from $301050.0 in Q1 2025, and up 100.34% quarter-over-quarter from $1.1 million in Q3 2025.
China SXT Pharmaceuticals (SXTC) Inventory (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Inventory history runs 9 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Inventory rose 623.83% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 623.83% YoY), while the FY2026 annual figure was $2.2 million, up 623.83% from the prior year.
- Inventory for Q1 2026 stood at $2.2 million, up from $1.1 million in the prior quarter.
- The five-year high for Inventory was $2.2 million in Q1 2026, with the low at $58128.0 in Q3 2022.
- The 5-year median for Inventory is $721318.0 (2024), against an average of $753227.1.
- The sharpest annual moves came in 2022 and 2024: Inventory slumped 89.11% in 2022, then soared 718.72% in 2024.
- China SXT Pharmaceuticals' Inventory stood at $58128.0 in 2022, then surged by 51.57% to $88103.0 in 2023, then jumped by 718.72% to $721318.0 in 2024, then soared by 50.79% to $1.1 million in 2025, then jumped by 100.34% to $2.2 million in 2026.
- Business Quant data shows SXTC's Inventory at $2.2 million in Q1 2026, $1.1 million in Q3 2025, and $301050.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 816.00 Mn |
| 10 | China SXT Pharmaceuticals | 32,029.07 | -28.14 Mn | - | 777,059.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 301,050.00 |
| Sep 30, 2024 | 721,318.00 |
| Mar 31, 2024 | 794,855.00 |
| Sep 30, 2023 | 88,103.00 |
| Mar 31, 2023 | 531,254.00 |
| Sep 30, 2022 | 58,128.00 |
| Mar 31, 2022 | 1.02 Mn |
| Sep 30, 2021 | 533,895.00 |
| Mar 31, 2021 | 859,696.00 |
| Sep 30, 2020 | 483,018.00 |
| Mar 31, 2020 | 892,767.00 |
| Sep 30, 2019 | 280,942.00 |
| Mar 31, 2019 | 1.01 Mn |
| Sep 30, 2018 | 322,420.00 |
| Mar 31, 2018 | 1.27 Mn |